Gerald D. Laubach
Plus aucun poste en cours
Profil
Gerald D.
Laubach, Ph.D., aged 78 years, has been the director of the Company since September 2002.
Dr. Laubach was President of Pfizer, Inc. from 1972 to 1990.
He is a member of the Institute of Medicine and the National Academy of Engineering.
He is a former director of Cigna Corporation, Pfizer Inc., Millipore Corporation and several biotechnology firms.
Dr. Laubach received a B.A.
from the University of Pennsylvania and a Ph.D.
in organic chemistry from the Massachusetts Institute of Technology.
Anciens postes connus de Gerald D. Laubach
| Sociétés | Poste | Fin |
|---|---|---|
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 17/03/2006 |
Formation de Gerald D. Laubach
| University of Pennsylvania | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
